Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Youyi Fong, Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez, Lisa M Dunkle, Iksung Cho, Christopher R Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Christos J Petropoulos, Andrew Leith, Deanne Haugaard, William Webb, Yiwen Lu, Chenchen Yu, Lindsay N Carpp, April K Randhawa, Michele P Andrasik, James G Kublin, Julia Hutter, Maryam Keshtkar-Jahromi, Tatiana H Beresnev, Carina A Rodriguez, Milagritos Tapia, Christine B Turley, Carmen D Zorrilla, Stuart H Cohen, Susan E Kline, Elizabeth Barranco, Lawrence Corey, Kathleen M Neuzil, Dean Follmann, Julie A Ake, Cynthia L Gay, Karen L Kotloff, Thomas Jones, Richard A Koup, Ruben O Donis, Peter B Gilbert

Open source

DOI: 10.1093/cid/ciaf558
Published: 2025-10-25
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciaf558,
  title = {Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine},
  author = {Youyi Fong and Yunda Huang and Ying Huang and Wayne Woo and Alice McGarry and Germán Áñez and Lisa M Dunkle and Iksung Cho and Christopher R Houchens and Karen Martins and Lakshmi Jayashankar and Flora Castellino and Christos J Petropoulos and Andrew Leith and Deanne Haugaard and William Webb and Yiwen Lu and Chenchen Yu and Lindsay N Carpp and April K Randhawa and Michele P Andrasik and James G Kublin and Julia Hutter and Maryam Keshtkar-Jahromi and Tatiana H Beresnev and Carina A Rodriguez and Milagritos Tapia and Christine B Turley and Carmen D Zorrilla and Stuart H Cohen and Susan E Kline and Elizabeth Barranco and Lawrence Corey and Kathleen M Neuzil and Dean Follmann and Julie A Ake and Cynthia L Gay and Karen L Kotloff and Thomas Jones and Richard A Koup and Ruben O Donis and Peter B Gilbert},
  year = {2025},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciaf558},
  url = {https://doi.org/10.1093/cid/ciaf558}
}

RIS

TY  - JOUR
TI  - Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine
AU  - Youyi Fong
AU  - Yunda Huang
AU  - Ying Huang
AU  - Wayne Woo
AU  - Alice McGarry
AU  - Germán Áñez
AU  - Lisa M Dunkle
AU  - Iksung Cho
AU  - Christopher R Houchens
AU  - Karen Martins
AU  - Lakshmi Jayashankar
AU  - Flora Castellino
AU  - Christos J Petropoulos
AU  - Andrew Leith
AU  - Deanne Haugaard
AU  - William Webb
AU  - Yiwen Lu
AU  - Chenchen Yu
AU  - Lindsay N Carpp
AU  - April K Randhawa
AU  - Michele P Andrasik
AU  - James G Kublin
AU  - Julia Hutter
AU  - Maryam Keshtkar-Jahromi
AU  - Tatiana H Beresnev
AU  - Carina A Rodriguez
AU  - Milagritos Tapia
AU  - Christine B Turley
AU  - Carmen D Zorrilla
AU  - Stuart H Cohen
AU  - Susan E Kline
AU  - Elizabeth Barranco
AU  - Lawrence Corey
AU  - Kathleen M Neuzil
AU  - Dean Follmann
AU  - Julie A Ake
AU  - Cynthia L Gay
AU  - Karen L Kotloff
AU  - Thomas Jones
AU  - Richard A Koup
AU  - Ruben O Donis
AU  - Peter B Gilbert
PY  - 2025
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciaf558
UR  - https://doi.org/10.1093/cid/ciaf558
ER  -

APA

Fong, Y., Huang, Y., Huang, Y., Woo, W., McGarry, A., Áñez, G., Dunkle, L. M., Cho, I., Houchens, C. R., Martins, K., Jayashankar, L., Castellino, F., Petropoulos, C. J., Leith, A., Haugaard, D., Webb, W., Lu, Y., Yu, C., Carpp, L. N., Randhawa, A. K., Andrasik, M. P., Kublin, J. G., Hutter, J., Keshtkar-Jahromi, M., Beresnev, T. H., Rodriguez, C. A., Tapia, M., Turley, C. B., Zorrilla, C. D., Cohen, S. H., Kline, S. E., Barranco, E., Corey, L., Neuzil, K. M., Follmann, D., Ake, J. A., Gay, C. L., Kotloff, K. L., Jones, T., Koup, R. A., Donis, R. O., & Gilbert, P. B. (2025). Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf558

Source records

crossref · retrieved 2026-09-26T08:01:13.481Z